In the frame of the HepHIV2019 conference taking place next week in Bucharest (28-30 January), the European AIDS Treatment Group and EuroTEST (formerly HIV in Europe) are co-hosting a multi-stakeholder breakfast meeting to discuss solutions to overcome practical challenges in implementing testing guidelines, the optimal use of new diagnostic technologies and evolution of diagnosis algorithms. Conference delegates that wish to participate can find more details below.
Implementing HIV, HBV and HCV testing guidance in the real world, beyond medical setting and using testing technology effectively
TESTING GUIDANCE AND DIAGNOSTICS MEETING
29 January at 7:00-8:30 am
Room Enescu 1, Athenee Palace Hilton, Strada Episcopiei 1-3, Bucharest
In July 2015, WHO issued a consolidated HIV testing guidance with the inclusion of community-based testing and in February 2017, WHO issued guidelines on testing for chronic HBV and HCV infection. In November 2018, ECDC published an evidence-based public health guidance addressing integrated HIV, HBV and HCV testing. The new ECDC’ guidance calls for integrated and concerted efforts of different actors to reduce the large number of those that are currently infected but undiagnosed, taking into consideration individual needs. The WHO and ECDC guidelines confirm the relevance of testing/screening closer to where people at-risk of infection frequent.
The advent of simplified, near to patient and polyvalent screening platforms for use beyond medical settings offers opportunities to improve screening and care models by facilitating earlier diagnosis and screening for the effectiveness of treatment and other related conditions.
Therefore, the EATG and EuroTEST (formerly HIV in Europe), would like to use the opportunity of the presence of key actors involved in screening at the HepHIV2019 conference to discuss what needs to be done to implement guidelines in the real world. The participants will discuss solutions to overcome practical challenges in implementing guidelines, the optimal use of new diagnostic technologies and evolution of diagnosis algorithms.
Objective of the meeting
The meeting should increase understanding of the new ECDC testing guidance, ways to foster implementation at the local level from the perspectives of different actors, as well as indications of further “game-changer” screening approaches to improve the health outcomes of key affected populations.
Format: multi-stakeholder breakfast workshop
Participants: ECDC, WHO, community and civil society organizations providing screening services, clinical societies, diagnostics companies, other national/international public health agencies
7:00 – 7:05 Introduction
7:05 – 7:15 What is new in the ECDC testing guidance, ECDC (Daniel Simões, EuroTEST Steering Committee Co-Chair, GAT, EATG, Coalition Plus)
7:15 –7:25 Debrief from WHO regional meeting on testing, WHO (Anton Mozalevskis, WHO)
7:25 – 7:35 Questions/feedback/challenges
7:35 – 08:05 Opportunities offered by new technologies and challenges, producers (Ray Ahmed, Orasure; Akli Bouaziz, AAZ, Siamak Tonekaboni, InTec)
08:05 – 08:20 Discussion on promising approaches/paths (Nikos Dedes, EATG Chair, Positive Voice, EuroTEST SC)
08:20 – 08:30 Wrap-up